{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:51:06Z","timestamp":1777535466672,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.brainres.2006.04.014","type":"journal-article","created":{"date-parts":[[2006,5,20]],"date-time":"2006-05-20T07:22:17Z","timestamp":1148109737000},"page":"96-106","source":"Crossref","is-referenced-by-count":17,"title":["Behavioral and physiological effects of a single injection of rat interferon-\u03b1 on male Sprague\u2013Dawley rats: A long-term evaluation"],"prefix":"10.1016","volume":"1095","author":[{"given":"A.C.","family":"Kentner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Miguelez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bielajew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2006.04.014_bib1","first-page":"R154","article-title":"Brain stem tonic inhibition of thermoregulation in the rat","volume":"247","author":"Amini-Sereshki","year":"1984","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.brainres.2006.04.014_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0889-1591(02)00100-9","article-title":"Sensitization associated with stressors and cytokine treatments","volume":"17","author":"Anisman","year":"2003","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2006.04.014_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002826-199412000-00001","article-title":"Interferons and multiple sclerosis","volume":"17","author":"Arnaso","year":"1994","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2006.04.014_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005650-197601000-00006","article-title":"The Sickness Impact Profile: validation of health status measure","volume":"14","author":"Bergner","year":"1976","journal-title":"Med. Care"},{"key":"10.1016\/j.brainres.2006.04.014_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-4328(03)00071-8","article-title":"Chronic interferon-\u03b1 potentiates latent inhibition in rats","volume":"144","author":"Bethus","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2006.04.014_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0361-9230(91)90230-H","article-title":"Neuromodulation of fever: apparent involvement of opioids","volume":"26","author":"Blatteis","year":"1991","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2006.04.014_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0031-9384(78)90050-1","article-title":"Increased efficiency of food utilization following weight loss","volume":"21","author":"Boyle","year":"1978","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainres.2006.04.014_bib8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0893-133X(99)00166-9","article-title":"Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations","volume":"22","author":"Brebner","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2006.04.014_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2003.11.004","article-title":"Baseline mood and psychosocial characteristics of patients developing symptoms during interleukin-2 and\/or interferon-alpha cancer therapy","volume":"18","author":"Capuron","year":"2004","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2006.04.014_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0006-8993(92)91106-O","article-title":"Behavioral effects of mouse interferons-\u03b1\u03b3 and -\u03b3 and human interferon-\u03b1 in mice","volume":"590","author":"Crnic","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2006.04.014_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/brbi.2000.0613","article-title":"Cytokine-induced sickness behavior: where do we stand?","volume":"15","author":"Dantzer","year":"2001","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2006.04.014_bib12","first-page":"334","article-title":"Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile","volume":"16","author":"Davis","year":"1994","journal-title":"Clin Ther."},{"key":"10.1016\/j.brainres.2006.04.014_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(03)02757-4","article-title":"The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus","volume":"977","author":"De La Garza","year":"2003","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.brainres.2006.04.014_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.pnpbp.2005.03.008","article-title":"Recombinant human interferon-alpha does not alter reward behavior, or neuroimmune and neuroendocrine activation in rats","volume":"29","author":"De La Garza","year":"2005","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2006.04.014_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0028-3908(90)90057-X","article-title":"Behavioral and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone","volume":"29","author":"De Sarro","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2006.04.014_bib16","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1172\/JCI111508","article-title":"Mechanisms of fever induced by recombinant human interferon","volume":"74","author":"Dinarello","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2006.04.014_bib17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/brbi.1993.1011","article-title":"Repeated injections of interferon-alpha A\/D in Balb\/c mice: behavioral effects","volume":"7","author":"Dunn","year":"1993","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2006.04.014_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1749-6632.1998.tb09596.x","article-title":"The role of cytokines in infection-related behavior","volume":"840","author":"Dunn","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2006.04.014_bib19","series-title":"Recent Studies of Hypothalamic Functions","first-page":"326","article-title":"Unit studies of brainstem projections to the pre-optic area and hypothalamus","author":"Eisenman","year":"1974"},{"key":"10.1016\/j.brainres.2006.04.014_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","article-title":"Biological basis of the behavior of sick animals","volume":"12","author":"Hart","year":"1988","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainres.2006.04.014_bib22","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1523\/JNEUROSCI.19-13-05654.1999","article-title":"Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations","volume":"19","author":"Hayley","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2006.04.014_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-5728(02)00259-X","article-title":"Murine tumor necrosis factor-\u03b1 sensitizes plasma corticosterone activity and the manifestation of shock: modulation by histamine","volume":"131","author":"Hayley","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainres.2006.04.014_bib24","series-title":"Statistical Methods for Psychology","author":"Howell","year":"2002"},{"key":"10.1016\/j.brainres.2006.04.014_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/00006454-199710000-00016","article-title":"Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis","volume":"16","author":"Iorio","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.brainres.2006.04.014_bib26","first-page":"117","article-title":"Binding of human alpha-interferon in the brain tissue membranes of the rat","volume":"75","author":"Janicki","year":"1992","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.brainres.2006.04.014_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0165-6147(92)90012-U","article-title":"Sickness behavior as a new target for drug development","volume":"12","author":"Kent","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2006.04.014_bib28","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1172\/JCI113467","article-title":"Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue","volume":"81","author":"Kettelhut","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2006.04.014_bib29","first-page":"R53","article-title":"Somnogenic effects of rabbit and recombinant human interferons in rabbits","volume":"267","author":"Kimura","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.brainres.2006.04.014_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1152\/physrev.1991.71.1.93","article-title":"Fever: role of pyrogens and cryogens","volume":"71","author":"Kluger","year":"1991","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.brainres.2006.04.014_bib31","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1046\/j.0953-816X.2000.01319.x","article-title":"The vagus nerve mediates behavioral depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis","volume":"12","author":"Konsman","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2006.04.014_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(00)02088-9","article-title":"Cytokine-induced sickness behaviour: mechanisms and implications","volume":"25","author":"Konsman","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2006.04.014_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0024-3205(00)00660-3","article-title":"Effect of interferon-\u03b1 on tyrosine hydroxylase and catecholamine levels in the brain of rats","volume":"67","author":"Kumai","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2006.04.014_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0006-8993(98)01288-8","article-title":"Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects","volume":"818","author":"Lacosta","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2006.04.014_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/brbi.2001.0643","article-title":"Behavioral effects of cytokines","volume":"15","author":"Larson","year":"2001","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2006.04.014_bib36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1210\/endo.135.2.7518383","article-title":"Local administration of recombinant human interleukin-1 beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic\u2013pituitary\u2013adrenocortical axis activity, and body temperature","volume":"135","author":"Linthorst","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.brainres.2006.04.014_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jad.2004.04.002","article-title":"The phenomenology and treatment of interferon-induced depression","volume":"82","author":"Loftis","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.brainres.2006.04.014_bib37","first-page":"R724","article-title":"Roles of interleukin 1 beta and tumor necrosis factor in lipopolysaccharide fever in rats","volume":"259","author":"Long","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.brainres.2006.04.014_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/0033-295X.105.1.83","article-title":"Cytokines for psychologists: implications of bidirectional, immune-to-brain communication for understanding behavior, mood, and cognition","volume":"105","author":"Maier","year":"1998","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.brainres.2006.04.014_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00474-9","article-title":"Enhancement of immobility in mouse forced swimming test by treatment with human interferon","volume":"356","author":"Makino","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2006.04.014_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s002130050031","article-title":"Human interferon-\u03b1 increases immobility in the forced swimming test in rats","volume":"148","author":"Makino","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2006.04.014_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbr.2004.02.022","article-title":"Short- and long-term effects of Interleukin-2 on weight, food intake, and hedonic mechanisms in the rat","volume":"154","author":"Miguelez","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2006.04.014_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0091-3057(97)00244-X","article-title":"Central administration of IL-1 reduced anxiety and induces sickness behavior in rats","volume":"58","author":"Montkowski","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2006.04.014_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2006.04.014_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jnr.490390105","article-title":"Fever and feeding in the rat: actions of intrahypothalamic interleukin-6 compared to macrophage inflammatory protein-1beta (MIP-1 beta)","volume":"39","author":"Myers","year":"1994","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2006.04.014_bib45","unstructured":"Nguyen, N.Y., 2003. Review-Peginterferon alfa-2a, Pegasys. United States Food and Drug Administration. www.fda.gov\/cder\/biologics\/review\/pegihof101602r1.pdf."},{"key":"10.1016\/j.brainres.2006.04.014_bib46","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1523\/JNEUROSCI.20-16-06289.2000","article-title":"Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin","volume":"20","author":"Opree","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2006.04.014_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-5728(97)00034-9","article-title":"Permeability of the blood\u2013brain and blood\u2013spinal cord barriers to interferons","volume":"76","author":"Pan","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainres.2006.04.014_bib48","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","article-title":"Interferons and their actions","volume":"56","author":"Pestka","year":"1987","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.brainres.2006.04.014_bib49","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0028-3908(94)90128-7","article-title":"Alpha-interferon suppresses food intake and neuronal activity of the lateral hypothalamus","volume":"33","author":"Reyes-Vazquez","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2006.04.014_bib50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0306-4530(00)00051-2","article-title":"Acute interferon-\u03b1 administration modulates sucrose consumption in the rat","volume":"26","author":"Sammut","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainres.2006.04.014_bib51","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0031-9384(02)00677-7","article-title":"Antidepressant reversal of interferon-\u03b1-induced anhedonia","volume":"75","author":"Sammut","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainres.2006.04.014_bib52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0014-2999(93)90588-9","article-title":"Alpha-interferon inhibits adrenocortical secretion via mu 1-opioid receptors in the rat","volume":"236","author":"Saphier","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2006.04.014_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/brbi.1994.1004","article-title":"Inhibition of neural and neuroendocrine activity by \u03b1-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat","volume":"8","author":"Saphier","year":"1994","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2006.04.014_bib54","unstructured":"Schering-Plough Research Institute, 2004. Interferon alfa-2b recombinant for injection: product information. United States Food and Drug Administration. http:\/\/www.fda.gov\/cder\/foi\/label\/2004\/103132_5064lbl.pdf."},{"key":"10.1016\/j.brainres.2006.04.014_bib55","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1037\/0735-7044.104.4.612","article-title":"An animal model for the behavioral effects of interferon","volume":"104","author":"Segall","year":"1990","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.brainres.2006.04.014_bib56","doi-asserted-by":"crossref","first-page":"13705","DOI":"10.1128\/JVI.79.21.13705-13713.2005","article-title":"Prophylactic alpha interferon treatment increases the therapeutic index of oncolytic vesicular stomatitis virus virotherapy for advanced hepatocellular carcinoma in immune-competent rats","volume":"79","author":"Shinozaki","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.brainres.2006.04.014_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/clpt.1985.16","article-title":"Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration","volume":"37","author":"Smith","year":"1985","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2006.04.014_bib57","first-page":"140","article-title":"Mapping the action of interferon on primate brain","volume":"6","author":"Smith","year":"1986","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.brainres.2006.04.014_bib59","series-title":"SPSS for Windows, Rel. 13.0","year":"2004"},{"key":"10.1016\/j.brainres.2006.04.014_bib60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000079415","article-title":"Influence of chronic interleukin-2 infusion and stressors on sickness behaviors and neurochemical change in mice","volume":"11","author":"Sudom","year":"2004","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.brainres.2006.04.014_bib61","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/jir.1996.16.1065","article-title":"Strain differences in the somnogenic effects of interferon inducers in mice","volume":"16","author":"Toth","year":"1996","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.brainres.2006.04.014_bib62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0361-9230(99)00203-8","article-title":"Cytokine\u2013cytokine interactions in the brain","volume":"51","author":"Turrin","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2006.04.014_bib63","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3181\/00379727-173-41649","article-title":"Circadian variation in circulating pyrogen: possible role in resistance to infection","volume":"173","author":"Ucar","year":"1983","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.brainres.2006.04.014_bib64","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1289\/ehp.99107s4619","article-title":"Species, interindividual, and tissue specificity in endocrine signalling","volume":"107","author":"Walker","year":"1999","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.brainres.2006.04.014_bib65","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0024-3205(95)02047-M","article-title":"Cytokine-to-brain communication: a review and analysis of alternative mechanisms","volume":"57","author":"Watkins","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2006.04.014_bib66","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/S1461145702003103","article-title":"The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans","volume":"5","author":"Wichers","year":"2002","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2006.04.014_bib67","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00187257","article-title":"Reduction of sucrose preference by chronic unpredictable mild stress and its restoration by a tricyclic antidepressant","volume":"93","author":"Willner","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2006.04.014_bib68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-8993(98)00904-4","article-title":"Interleukin-2 and -6 induce behavioral-activating effects in mice","volume":"811","author":"Zalcman","year":"1998","journal-title":"Brain Res."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899306010377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899306010377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T19:18:11Z","timestamp":1555615091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899306010377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0006899306010377"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2006.04.014","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}